Healthcare -
Biotechnology - NASDAQ - US
$ 31.23
0.872 %
$ 12 B
Market Cap
-3.37
P/E
MRNA - STOCK-BASED COMPENSATION
Stock-based Compensation MRNA - Moderna, Inc.
429 M
LAST VALUE
37.78%
2 YEAR CAGR
39.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR